Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Cell Reports|May 10, 2018
TIM-1 Ubiquitination Mediates Dengue Virus EntryOphélie Dejarnac, Mohamed Lamine Hafirassou, Maxime Chazal, et al.
Open Forum Infectious Diseases|March 15, 2024
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized TrialLara E Coelho, Corine Chazallon, Didier Laureillard, et al.
The Lancet. Infectious Diseases|April 15, 2014
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trialBeatriz Grinsztejn, Nathalie De Castro, Vincent Arnold, et al.
The Journal of Antimicrobial Chemotherapy|April 8, 2020
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial)Cathia Soulie, Lambert Assoumou, Basma Abdi, et al.
The Lancet. Infectious Diseases|March 5, 2021
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trialNathalie De Castro, Olivier Marcy, Corine Chazallon, et al.
Journal of Viral Hepatitis|April 12, 2019
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infectionRomina Salpini, Arianna Battisti, Luna Colagrossi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2025
Alterations of anti-SARS-CoV-2 immune response in children vary according to the nature of their immunosuppressionIsabelle Nel, Marine Minier, Anastasia Milojkovic, et al.
Clinical Pharmacology and Therapeutics|October 5, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisGuillaume Lingas, Delphine Planas, Hélène Péré, et al.
The Lancet. Infectious Diseases|November 29, 2021
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trialConstance Delaugerre, Frantz Foissac, Hendy Abdoul, et al.
Frontiers in Immunology|December 12, 2022
Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate modelEmma Lorenzen, Vanessa Contreras, Anja W Olsen, et al.
Pageof 23